|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 120, Issue 8 2259-2269, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
DA Rappolee, C Basilico, Y Patel and Z Werb
Laboratory of Radiobiology and Environmental Health, University of California, San Francisco 94143-0750.
One of the earliest events in mammalian embryogenesis is the formation of the inner cell mass (ICM) and the subsequent delamination of primitive endoderm. We have found that mRNA for fibroblast growth factor (FGF)-4, but not FGF-3, is expressed in preimplantation mouse blastocysts and that the FGF-4 polypeptide is present in ICM cells. ICM-like embryonal carcinoma cells and embryonic stem cells also express FGF-4. Conversely, differentiated embryonal carcinoma cells in the endoderm lineage express FGF-3, but not FGF-4 mRNA. Although mouse embryos expressed FGF-4 mRNA from the 1-cell stage, embryos cultured from the 2-cell through the blastocyst stage in the presence of recombinant FGF-4 did not respond mitogenically. However, when ICMs that were isolated by immunosurgery were cultured with FGF-4, the number of morphologically distinct, differentiated parietal endoderm cells growing out onto the coverslip increased, without an increase in the number of undifferentiated ICM cells. ICM outgrowths cultured with FGF-4 increased their secretion of 92 x 10(3) M(r) gelatinase and tissue plasminogen activator, a hallmark of migrating cells. Receptors for FGF-4 (FGFR-3 and FGFR-4) are expressed in all cells of the mouse blastocyst. These findings indicate that FGF-4 produced by undifferentiated ICM cells acts in the peri-implantation period of embryogenesis to influence the production and behavior of endoderm cells derived from them.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  A. D Metcalfe and M. W.J Ferguson Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration J R Soc Interface, June 22, 2007; 4(14): 413 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Ribas, J. E. Taylor, C. McCorquodale, A. C. Mauricio, M. Sousa, and I. Wilmut Effect of Zona Pellucida Removal on DNA Methylation in Early Mouse Embryos Biol Reprod, February 1, 2006; 74(2): 307 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Martinez-Ceballos, P. Chambon, and L. J. Gudas Differences in Gene Expression between Wild Type and Hoxa1 Knockout Embryonic Stem Cells after Retinoic Acid Treatment or Leukemia Inhibitory Factor (LIF) Removal J. Biol. Chem., April 22, 2005; 280(16): 16484 - 16498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Desmarais, V. Bordignon, F. L. Lopes, L. C. Smith, and B. D. Murphy The Escape of the Mink Embryo from Obligate Diapause Biol Reprod, March 1, 2004; 70(3): 662 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Uy, K. M. Downs, and R. L. Gardner Inhibition of trophoblast stem cell potential in chorionic ectoderm coincides with occlusion of the ectoplacental cavity in the mouse Development, March 10, 2003; 129(16): 3913 - 3924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Avilion, S. K. Nicolis, L. H. Pevny, L. Perez, N. Vivian, and R. Lovell-Badge Multipotent cell lineages in early mouse development depend on SOX2 function Genes & Dev., January 1, 2003; 17(1): 126 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rossant Stem Cells from the Mammalian Blastocyst Stem Cells, November 1, 2001; 19(6): 477 - 482. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Tanaka, T. Kunath, A. Hadjantonakis, A. Nagy, and J. Rossant Promotion of Trophoblast Stem Cell Proliferation by FGF4 Science, December 11, 1998; 282(5396): 2072 - 2075. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Resnick, M. Ortiz, J. R. Keller, and P. J. Donovan Role of Fibroblast Growth Factors and Their Receptors in Mouse Primordial Germ Cell Growth Biol Reprod, November 1, 1998; 59(5): 1224 - 1229. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Arman, R. Haffner-Krausz, Y. Chen, J. K. Heath, and P. Lonai Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development PNAS, April 28, 1998; 95(9): 5082 - 5087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Dvorak, J. Flechon, E. Thompson, V Horak, P Adenot, and J. Renard Embryoglycans regulate FGF-2-mediated mesoderm induction in the rabbit embryo J. Cell Sci., January 1, 1997; 110(1): 1 - 10. [Abstract] [PDF]
|
|
|
|
|
|
L E Stephens, A E Sutherland, I V Klimanskaya, A Andrieux, J Meneses, R A Pedersen, and C H Damsky Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes & Dev., August 1, 1995; 9(15): 1883 - 1895. [Abstract] [PDF]
|
|
|
|
|
|
B Feldman, W Poueymirou, V. Papaioannou, T. DeChiara, and M Goldfarb Requirement of FGF-4 for postimplantation mouse development Science, January 13, 1995; 267(5195): 246 - 249. [Abstract] [PDF]
|
|
|
|
|
|
O Behrendtsen, C. Alexander, and Z Werb Cooperative interactions between extracellular matrix, integrins and parathyroid hormone-related peptide regulate parietal endoderm differentiation in mouse embryos Development, January 12, 1995; 121(12): 4137 - 4148. [Abstract] [PDF]
|
|
|
|
|
|
E. Newman-Smith and Z Werb Stem cell defects in parthenogenetic peri-implantation embryos Development, January 7, 1995; 121(7): 2069 - 2077. [Abstract] [PDF]
|
|
